Lenacapavir LPE intermediate impurity

2189684-58-8

Lenacapavir LPE intermediate impurity

Product

Lenacapavir

Impurity

Lenacapavir LPE intermediate impurity

CAS No.

2189684-58-8

Chemical name

(3bS,4aR)-N-[(1S)-1-[3-[3-[Bis(methylsulfonyl)amino]-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide

Synonyms

1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide, N-[(1S)-1-[3-[3-[bis(methylsulfonyl)amino]-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)

Molecular Formula

C40H34ClF10N7O7S3

Molecular Weight

1046.38

Appearance

An off-white solid

Typical purity

NLT 97% (HPLC)

Description :- NIL

Vision

Vision

A world closer to sustainability and safety through Pharma chemical research and development.

Mission

Mission

Becoming the world's best pharma chemical industry with value contribution and quality service that benefits core tes and entire human race.

2189684-58-8